These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27203158)

  • 1. [Early adherence to anti-glaucoma therapy: An observational study].
    Belhassen M; Laforest L; Licaj I; Van Ganse É
    Therapie; 2016 Oct; 71(5):491-499. PubMed ID: 27203158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistency with medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994-2005.
    Owen CG; Carey IM; de Wilde S; Whincup PH; Wormald R; Cook DG
    Eye (Lond); 2009 May; 23(5):1098-110. PubMed ID: 18617908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence and adherence with topical glaucoma therapy.
    Nordstrom BL; Friedman DS; Mozaffari E; Quigley HA; Walker AM
    Am J Ophthalmol; 2005 Oct; 140(4):598-606. PubMed ID: 16226511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence and Persistence with First-Line Therapy and Compliance with Glaucoma Guidelines Using Japanese Health Care/Pharmacy Claims Database.
    Shirai C; Matsuoka N; Nakazawa T
    J Ocul Pharmacol Ther; 2021; 37(1):35-44. PubMed ID: 33370214
    [No Abstract]   [Full Text] [Related]  

  • 5. [New medical treatments of glaucoma. New strategies?].
    Renard JP; May F; Rigal-Sastourne JC; Maurin JF
    J Fr Ophtalmol; 2001 Dec; 24(10):1095-9. PubMed ID: 11913242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of adverse events in self-reported sulfa-allergic patients using topical carbonic anhydrase inhibitors.
    Guedes GB; Karan A; Mayer HR; Shields MB
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):456-61. PubMed ID: 23445203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistency rates for prostaglandin and other hypotensive eyedrops: population-based study using pharmacy claims data.
    Rait JL; Adena MA
    Clin Exp Ophthalmol; 2007; 35(7):602-11. PubMed ID: 17894679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changing trends of topical anti-glaucoma medications in the Eye Hospital of Wenzhou Medical University during the past ten years].
    Liang YB; Wu HX; Liao N; Li M; Zhang Q; Wang PJ; Zheng JW; Fang AW; Qu J
    Zhonghua Yan Ke Za Zhi; 2018 Jul; 54(7):520-525. PubMed ID: 29996614
    [No Abstract]   [Full Text] [Related]  

  • 9. Glaucoma medications and mortality: a retrospective cohort study.
    French DD; Margo CE
    Ann Epidemiol; 2010 Dec; 20(12):917-23. PubMed ID: 21074106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical therapies for glaucoma: what family physicians need to know.
    Lewis PR; Phillips TG; Sassani JW
    Am Fam Physician; 1999 Apr; 59(7):1871-9, 1882. PubMed ID: 10208706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices.
    Pajic B;
    Curr Med Res Opin; 2003; 19(2):95-101. PubMed ID: 12740152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Maccabi Glaucoma Study: Treatment Patterns and Persistence With Glaucoma Therapy in a Large Israeli Health Maintenance Organization.
    Goldshtein I; Shalev V; Zigman N; Chodick G; Levkovitch-Verbin H
    J Glaucoma; 2016 Apr; 25(4):e386-91. PubMed ID: 26900826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glaucoma medications: a drug-therapy review.
    Fiscella RG
    Manag Care; 2002 Nov; 11(11 Suppl):25-31. PubMed ID: 15357536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical management of the childhood glaucomas.
    Talbot AW; Russell-Eggitt I
    Expert Opin Pharmacother; 2000 May; 1(4):697-711. PubMed ID: 11249511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribing Trends in a Glaucoma Clinic and Adherence to EGS Guidelines: A Retrospective, Non-Interventional, Single-Center UK Study.
    Fajgenbaum M; Ansari E
    Adv Ther; 2017 Aug; 34(8):2033-2042. PubMed ID: 28726170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary drug treatment for glaucoma: beta-blockers versus other medications.
    Stamper RL; Wigginton SA; Higginbotham EJ
    Surv Ophthalmol; 2002; 47(1):63-73. PubMed ID: 11801272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary open angle glaucoma: an overview on medical therapy.
    Vetrugno M; Cantatore F; Ruggeri G; Ferreri P; Montepara A; Quinto A; Sborgia C
    Prog Brain Res; 2008; 173():181-93. PubMed ID: 18929109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence with topical glaucoma therapy among newly diagnosed Japanese patients.
    Kashiwagi K; Furuya T
    Jpn J Ophthalmol; 2014 Jan; 58(1):68-74. PubMed ID: 24408788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of topical glaucoma medication: a nationwide population-based cohort study in Taiwan.
    Hwang DK; Liu CJ; Pu CY; Chou YJ; Chou P
    JAMA Ophthalmol; 2014 Dec; 132(12):1446-52. PubMed ID: 25211300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A history of glaucoma pharmacology.
    Realini T
    Optom Vis Sci; 2011 Jan; 88(1):36-8. PubMed ID: 21131876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.